Intestinal Gluconeogenesis: Emerging Regulator of Energy Homeostasis
The IGN project aims to understand and manipulate intestinal gluconeogenesis to control obesity and diabetes through neural mechanisms and novel metabolites for better metabolic health.
Projectdetails
Introduction
Obesity and type 2 diabetes continuously progress worldwide, compromising healthy aging. Deregulated endogenous glucose production (EGP) is involved in hyperglycemia and its complications. Among the 3 organs (liver, kidney, intestine) contributing to EGP, I uncovered with my team that intestinal gluconeogenesis (IGN) has the capacity to interfere in the control of energy homeostasis.
Gut-Brain Circuit
Indeed, intestinal glucose initiates a gut-brain circuit controlling both body weight and glucose production by the liver, the strongest quantitative contributor to EGP. Intestinal gluconeogenesis is, thus, a novel target to control obesity and diabetes.
Project Objectives
The IGN project has 3 objectives:
1. Understand
This objective is dedicated to elucidating the neural mechanisms by which IGN is sensed and sends its signals to the brain. Our data suggested that glucose receptor sodium-glucose co-transporter 3 (SGLT3) could be the peripheral sensor of IGN. Moreover, we showed that the neuromediator calcitonin gene-related peptide alpha (CGRPa) is mandatory for the IGN signal. I will use original mouse models to map the SGLT3-neuron connection to the brain and define the role of CGRPa.
2. Explore
This objective aims at expanding the scope of IGN to the networking of the hypothalamus during the neonatal period. I will assess whether the surge of IGN occurring during the neonatal period may control the development of neuronal connections between the hypothalamic nuclei, to ensure an optimal control of energy homeostasis in adulthood, as previously observed for the neonatal surge of the hormone leptin.
3. Take Advantage
This objective aims at identifying novel metabolites able to activate IGN and test them as beneficial modulators of energy homeostasis under unbalanced nutrition. This will pave the way to novel therapeutic approaches for metabolic diseases based on IGN.
Conclusion
Thus, the IGN project should lead to a better understanding of metabolic control and offer new perspectives for preventing metabolic diseases and maintaining healthy aging.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.500.000 |
Totale projectbegroting | € 2.500.000 |
Tijdlijn
Startdatum | 1-10-2023 |
Einddatum | 30-9-2028 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSpenvoerder
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
CenTral and PeRipheral NervoUs SyStem acTion of GIPR in ObEsity and DiabetesThis project aims to elucidate the mechanisms of GIPR (ant)agonists and GLP-1R/GIPR co-agonists in regulating energy and glucose metabolism to inform future obesity drug development. | ERC Consolid... | € 1.999.928 | 2022 | Details |
Deconstructing Hypothalamic Neurocircuitry Architecture and Function in Metabolic Control during Health and DiseaseThis project aims to map hypothalamic neuron types and circuits involved in body weight regulation to enhance understanding and treatment of obesity and related metabolic diseases. | ERC Advanced... | € 2.500.000 | 2025 | Details |
Deciphering cellular and molecular mechanisms of β-cell regenerationBetaRegeneration aims to develop targeted therapies for diabetes by enhancing beta-cell protection and regeneration through novel druggable targets and combinatorial approaches. | ERC Advanced... | € 2.446.645 | 2022 | Details |
Paracrine signalling in alpha cells and the integration of mechanisms that control glucagon secretionThis project aims to investigate how insulin and somatostatin regulate alpha cell metabolism and glucagon secretion, exploring their roles in hyperglucagonaemia and diabetes using advanced measurements and models. | ERC Starting... | € 1.659.836 | 2023 | Details |
Harnessing an energy-expending, appetite-suppressing fat-brain axis to unlock novel pharmacotherapiesThe HEAT-UP project aims to explore a novel leptin-independent signaling axis between adipose tissue and the CNS to enhance calorie-burning and reduce obesity, leveraging advanced genetic and viral techniques. | ERC Consolid... | € 2.000.000 | 2023 | Details |
CenTral and PeRipheral NervoUs SyStem acTion of GIPR in ObEsity and Diabetes
This project aims to elucidate the mechanisms of GIPR (ant)agonists and GLP-1R/GIPR co-agonists in regulating energy and glucose metabolism to inform future obesity drug development.
Deconstructing Hypothalamic Neurocircuitry Architecture and Function in Metabolic Control during Health and Disease
This project aims to map hypothalamic neuron types and circuits involved in body weight regulation to enhance understanding and treatment of obesity and related metabolic diseases.
Deciphering cellular and molecular mechanisms of β-cell regeneration
BetaRegeneration aims to develop targeted therapies for diabetes by enhancing beta-cell protection and regeneration through novel druggable targets and combinatorial approaches.
Paracrine signalling in alpha cells and the integration of mechanisms that control glucagon secretion
This project aims to investigate how insulin and somatostatin regulate alpha cell metabolism and glucagon secretion, exploring their roles in hyperglucagonaemia and diabetes using advanced measurements and models.
Harnessing an energy-expending, appetite-suppressing fat-brain axis to unlock novel pharmacotherapies
The HEAT-UP project aims to explore a novel leptin-independent signaling axis between adipose tissue and the CNS to enhance calorie-burning and reduce obesity, leveraging advanced genetic and viral techniques.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Linking Intestinal Bacteria and Host Metabolism to Tackle Type 2 Diabetes with Novel FoodDiBaN aims to develop advanced platforms for testing novel insect-based foods to prevent intestinal dysbiosis and Type 2 diabetes, integrating AI for personalized nutritional interventions. | EIC Pathfinder | € 3.999.222 | 2024 | Details |
Glucose variability patterns for precision nutrition in diabetesThe GLUCOTYPES project aims to identify early glycaemic patterns and their dietary influences using advanced technologies to develop precision nutrition strategies for Type 2 diabetes prevention and management. | EIC Pathfinder | € 3.988.206 | 2024 | Details |
Linking Intestinal Bacteria and Host Metabolism to Tackle Type 2 Diabetes with Novel Food
DiBaN aims to develop advanced platforms for testing novel insect-based foods to prevent intestinal dysbiosis and Type 2 diabetes, integrating AI for personalized nutritional interventions.
Glucose variability patterns for precision nutrition in diabetes
The GLUCOTYPES project aims to identify early glycaemic patterns and their dietary influences using advanced technologies to develop precision nutrition strategies for Type 2 diabetes prevention and management.